Juluca 50 mg (Dolutegravir (Dolutegravir Sodium) TABLET) 50 MG

Juluca 50 mg tablets contain dolutegravir, an antiretroviral medication used in HIV treatment. This oral tablet is manufactured by ViiV Healthcare ULC in Canada.

Strength

50 MG

Pack Size

Manufacturer / TM Owner

VIIV HEALTHCARE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Juluca 50 mg tablets are primarily used as part of a combination therapy to manage HIV-1 infection in adults and children weighing at least 40 kg. Dolutegravir, the active ingredient, works by inhibiting the integrase enzyme, which is crucial for the HIV virus to multiply. This helps to reduce the amount of HIV in the body, improving immune function and reducing the risk of HIV-related illnesses. Juluca is often prescribed alongside other antiretroviral drugs to create a comprehensive treatment regimen.

Side Effects

Common effects of Juluca 50 mg tablets may include headache, fatigue, and nausea. Some individuals might experience dizziness, insomnia, or abdominal discomfort. These effects vary among users and are not experienced by everyone. If any effects are severe or persistent, it is important to consult a healthcare provider.

Precautions & Warnings

Juluca 50 mg tablets should be handled with care, stored at room temperature, and kept out of reach of children. It is important to follow the prescribed dosage and not to share this medication with others. Regular medical check-ups are recommended to monitor the effectiveness and any potential side effects of the treatment.

Avoid Interactions

Juluca 50 mg tablets may interact with certain medications, including antacids, laxatives, and other drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate some side effects.

Frequently Asked Questions

Juluca 50 mg tablets are used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and children weighing at least 40 kg.

Juluca 50 mg tablets should be stored at room temperature, away from moisture and heat, and out of reach of children.

Common side effects may include headache, fatigue, nausea, dizziness, insomnia, and abdominal discomfort.

Juluca 50 mg may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Juluca 50 mg is approved for use in children weighing at least 40 kg, but it should be administered under the supervision of a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.